Women pregnancy and methadone treatment
DOI:
https://doi.org/10.20882/adicciones.433Keywords:
drug dependency, women, pregnancy, methadone, epidemiologyAbstract
Analysis of the specific needs of pregnant drug-dependent women at the commencement of and during treatment with methadone, on the basis of a sample of 119 women who requested treatment, in a national study in France on drug addicts undergoing treatment. 66% of the sample were addicted to heroin and 15% to buprenorphine. During treatment, it could be seen that there was an increase in the average prescribed doses of methadone, which favoured an improvement in the general situation and a reduction in the necessary consultations. In line with our study, international studies with both women cocaine dependents and heroin dependents also indicate how both the demand for treatment and the continuance of the treatment with methadone was easier if the treatment team provided psychoeducational support, in connection with the family environment, wherever possible, to facilitate the existence of a project for the future child. Our study shows that pregnant women do ask for assistance from specialist centres but, on occasion, the difficulties that arise when undergoing treatment leads them to abandon it early. Pregnancy should be considered to be a privileged moment to approach the problems of drug abuse and as a moment during which it is easier to motivate women to take treatment. The articulation between the drug dependency, gynaecological and paediatric teams must be improved.References
Batey R.G., Weissel K. (1993) A 40 month follow-up of pregnant drug using women treated at Westmead Hospital. Drug and Alcohol Review, 12: 265-270.
Boer K., Smit B.J., Van Huis A.M., Hogerzeil H.V (1994) Substance abuse in pregnancy: do we can? Acta paediatrica Scandinava. Supplément, 404: 65-71.
Chang G., Carroll K.M., Behr H.M., Kosten T.R. (1992) Improving treatment outcome in pregnant opiatedependent women. Journal of substance Abuse Treatment, 9: 327-330.
Depetrillo P, Rice J.M. (1995) Methadone dosing and pregnancy: impact on program compliance. International Journal of the Addictions, 30, (2): 207-217.
Facy F. (1999) Toxicomanes et prescription de méthadone.
Paris, EDK. 128p.
Finnegan L.P. (1995) Addiction and pregnancy: maternal and
child issues. In: Tagliamonte A., Maremmani I., Drug addiction and related clinical problems. New-York, Springer-Verlag Wien: 137-147.
Fischer G., Jagsch R., Eder H., Gombas W., Etzersdorfer P.,
Schmidl-Mohl C., Schatten C., Weninger M., Aschauer H.N (1999). Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction, 94 (2): 231-239.
Guyon L. (2003) Les femmes et les substances psychoactives: impact des rôles sociaux. In: Facy F., Guyon L, Les toxicomanies. Paris, EDK: 186-203.
Guyon L, De Koninck M, Morissette P, Chayer L. (2003) Maternité et toxicomanie: la réalité plutôt que la fiction. In: Facy F., Guyon L, Les toxicomanies. Paris, EDK: 263-274.
Jarvis M.A.E., Wu-Pong S., Kniseley J.S., Schnoll S.H. (1999)
Alterations in methadone metabolism during late pregnancy. Journal of Addictive Diseases, 18, (4): 51-61.
Mc Lean A. (1994) ‘The little people therapeutic projet’ - Ethique et valeurs idéologiques à propos de quatre années de travail aux Etats-Unis de 1987 à 1991. Information Psychiatrique, 70 (2): 163-171.
Offidani C., Chiarotti M., De Giovanni N., Falasconi A.M. (1986) Methadone in pregnancy: clinical, toxicological aspects. Clin Toxicol 24: 295-303.
Picard E. (1995) Méthadone and pregnancy. Archives of public
health, 53, (5-6): 183-205.
T3E. (1997) Les traitements de substitution en Europe. Cahiers T3E, (2): 189p.
Wieviorka S. (1994) Grossesse et toxicomanie: une multiplicité des risques. Revue du Praticien, 8, (247): 37-41.
